Business
Merck drug less effective against moderate COVID -India regulatory source – Reuters
Merck & Co’s (MRK.N) experimental antiviral drug molnupiravir has not shown “significant efficacy” against moderate COVID-19,…
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermidNEW DELHI, Oct 8 (Reuters) – Merck & Co’s (MRK.N) experimental antiviral drug molnupiravir has not shown “significant efficacy”…
Continue Reading
-
General22 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News23 hours agoPolice appeal for information after two men found dead
-
General23 hours agoTariff letters to 12 countries going out Monday: Trump
-
General23 hours agoCan the world be governed without the US? • Inside Story